This work provides a review of the state of the art of targeted cancer therapy, covering new and emerging technologies in target identification, drug discovery, molecular markers, and imaging. In addition to detailing the development and effects of drugs that directly impact the molecular abnormality that characterizes a tumor in various types of cancers, the book reports on targeted and functional imaging, drug combinations for overcoming drug resistance, and drug development approaches. The readership for the book includes physicians, fellows, residents, and students, as well as basic scientists. The editors are affiliated with the MD Anderson Cancer Center at The University of Texas. Annotation ©2008 Book News, Inc., Portland, OR (booknews.com)